Associated factors of Gestational Trophoblastic Disease: 5 Year Experience in Buddhachinaraj Phitsanulok Hospital

Main Article Content

Danai Sungsub

Abstract

Introduction: Gestational trophoblastic disease (GTD) consists of molar pregnancy and choriocarcinoma. It is derived from abnormal proliferation of pregnancy related trophoblastic cell. It is more frequently found in oriental 5-10 times than in western world. Objective: To verify the relationship between its occurrence and numbers of pregnancy as well as maternal age and to identify its leading problems. Patients & Methods: Medical records of GTD in Buddhachinaraj Phitsanulok Hospital, Phitsanulok during 2000-2004 were retrospectively reviewed and compared to control. The control group was randomly selected from normal pregnant women who attended antenatal care within the same month and year as GTD. Results: The prevalence of GTD was 1.75:1,000, it did not relate to maternal age (p>0.05). Mean age was 26.7 ± 10.2 years. About numbers of pregnancy, in cases of more than 2, every pregnancy could significantly raise 1.5 folds of the risk of GTD (p<0.05). The most common leading problem was spotted vaginal bleeding (63.6%), the second common was spotted bleeding with frank mole (13.6%). Conclusion: During year 2000-2003, 22 GTD cases were diagnosed in Buddhachinaraj Phitsanulok Hospital, Phitsanulok by pathologist. Mean age was 26.7 ± 10.2 years. Its occurrence was found relating to numbers of pregnancy, not to maternal age.

Article Details

How to Cite
Sungsub , D. (2024). Associated factors of Gestational Trophoblastic Disease: 5 Year Experience in Buddhachinaraj Phitsanulok Hospital. Maharat Nakhon Ratchasima Hospital Journal, 29(3), 167–174. Retrieved from https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/2077
Section
Original Article

References

Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydratidiform mole and subsequent pregnancy outcome following complete or partial hydratidiform molar pregnancy. BJOG 2003; 110: 22-6

Fallahian M. Familial gestational trophoblastic disease. Placenta 2003; 24: 797-9.

Chong CY, Koh CF. Hydratidiform mole in Kandang Kerbau Hospital-A 5 Year Review. Singapore Med J 1999; 40: 256-70.

ธีระ ทองสง, จตุพล ศรีสมบูรณ์, อภิชาต โอฬารรัตนชัย. นรีเวชวิทยา (ฉบับสอบบอร์ดเรียบเรียง ครั้งที่ 2: 2539). กรุงเทพมหานคระ พี.บี. ฟอเรน บุ๊คส์ เซนเตอร์, 2539; หน้า 279-93.

Steigard SJ. Epidemioblogy of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gygaecol 2003;17: 837-47.

Altieri A, Franceschi S, Ferlay Smith I, La Vocchai C. Epidemiology and actiology of gestational trophoblastic disease. Lancet Oncol 2003; 4: 670-8.

Khoo SK. Clinical aspects of gestational troblastic disease: a review based partly on 25-year experience of a statewide registry. Aust N Z Obstet Gynaecol 2003; 43: 280-9.

Djamhoer M. Gestational Trophoblastic Discase-Detection and Management. J Paeds Obstet Gynecol 1991; May/June: 5-10.

Berkowitz RS, Goldstien DP, Bemstien MR, Sablinski B. Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumours. Re- prod Med 1987; 32: 680-4.

Bagshawe KD. Risk and Prognostic Factor in Tropho~ blastic Neoplasis. Cancer 1976; 38: 1373-85.